Frequently Asked Questions
SubMagna™ Semaglutide and Tirzepatide Sublingual Suspension is a liquid medication formulated for sublingual administration. It is dispensed in a dropper bottle for precise dosing and is designed to be dropped directly under the tongue, where it forms an emulsion with saliva to enhance the absorption of the active pharmaceutical ingredient (API).
The active ingredients from Semaglutide in SubMagna is sourced directly from Novo Nordisk, the manufacturer of and Ozempic®. Tirzepatide is sourced directly from Mounjaro®.
SubMagna™ SL HMW is an advanced sublingual suspension vehicle that is anhydrous, self-emulsifying, and permeation-enhancing. It is specifically designed to deliver drugs with varying molecular weights, including high molecular weight substances like Semaglutide and Tierzepatide. Its unique properties allow for improved solubility, dispersibility, and mucoadhesion, which leads to greater absorption of the medication through the mucosal tissues.
Sublingual administration offers several benefits, including faster onset of action, avoidance of gastrointestinal degradation, and reduced impact of hepatic first-pass metabolism. This results in improved bioavailability of the medication. Additionally, the sublingual route is convenient for patients who have difficulty swallowing tablets or capsules or do not want an injection.
Store the SubMagna™ Sublingual Suspension at room temperature, away from direct light and heat. Keep the bottle tightly closed when not in use. Refer to the product label or consult your pharmacist for specific storage instructions.
As with any medication, SubMagna™ Semaglutide and Tirzepatide Sublingual Suspension may cause side effects. Being on an appetite suppressor can also suppress thrist. It is imperative to consume daily recommended amount of water to help mitigate side effects. Side effects can include nausea, vomiting, diarrhea, and abdominal pain. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
It is important to discuss all medications, supplements, and over-the-counter drugs you are taking with your healthcare provider to ensure that Semaglutide or Tirzepatide Sublingual Suspension is compatible. Some medications may interact with SubMagna™ Semaglutide, affecting its efficacy or increasing the risk of side effects. Check with physician before taking Aspirin, other medicine for appetite suppression. Check in for medication combined with Sulfonylureas or insulin as it may cause may cause low blood sugar.
To use the SubMagna™ Sublingual Suspension, simply use the dropper provided to dispense the prescribed number of drops under your tongue. Hold the suspension sublingually for 90 seconds before swallowing to allow for maximum absorption. Most absorption happens within the first 30 seconds.
It is generally recommended to wait a few minutes after taking the sublingual suspension before eating or drinking. This allows the medication to be fully absorbed through the sublingual mucosa. Follow your healthcare provider's specific instructions regarding food and drink restrictions. It is recommended to not mix alcohol and Semaglutide or Tirzepatide.
While the dropper bottle design is often used for medications requiring smaller doses or for pediatric patients, the suitability of SubMagna™ Sublingual Suspension for children depends on the specific medication indications and should be determined by a healthcare provider.
If you miss a dose of SubMagna™ Sublingual Suspension, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double the dose to catch up. Always consult with your healthcare provider for personalized advice on missed doses.
The beyond-use-date for SubMagna™ Semaglutide and Tirzepatide Sublingual Suspension can vary based on the specific formulation and storage conditions. The anhydrous nature of SubMagna™ SL HMW base may offer the potential for longer BUDs. Always check the expiration date on the bottle. The expiration of the compound is 3 months from compounding date.